sns-301
Showing 1 - 2 of 2
Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
- SNS-301
- Pembrolizumab
-
San Francisco, California
- +9 more
Dec 6, 2022
MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)
Withdrawn
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia (CMML)
- SNS-301
- (no location specified)
Aug 9, 2021